Epigenetic dysregulations associated with aging implicate intense health concerns for numerous pathologies including metabolic and cardiovascular diseases, cancer, psychiatric and neurodegenerative disorders. Epigenetic drugs-based therapy has emerged as a potential strategy for treating certain agingassociated diseases. Epigenetic modifications are known to be reversible, which makes them suitable targets for pharmacological intervention.